vs
Side-by-side financial comparison of Bath & Body Works, Inc. (BBWI) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
Bath & Body Works, Inc. is the larger business by last-quarter revenue ($1.6B vs $1.5B, roughly 1.1× BeOne Medicines Ltd.). Bath & Body Works, Inc. runs the higher net margin — 4.8% vs 4.4%, a 0.4% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs -1.0%). BeOne Medicines Ltd. produced more free cash flow last quarter ($379.8M vs $-1.0M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs -26.0%).
Bath & Body Works, Inc. is an American specialty retail company based in Columbus, Ohio. It owns Bath & Body Works, posted $7.4 billion in revenue in 2023, and was listed as 481 on the 2024 Fortune 500 list of largest United States companies by revenue.
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
BBWI vs ONC — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.6B | $1.5B |
| Net Profit | $77.0M | $66.5M |
| Gross Margin | 41.3% | 90.5% |
| Operating Margin | 10.1% | 12.4% |
| Net Margin | 4.8% | 4.4% |
| Revenue YoY | -1.0% | 32.8% |
| Net Profit YoY | -27.4% | 143.8% |
| EPS (diluted) | $0.37 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.6B | $1.5B | ||
| Q3 25 | $1.5B | $1.4B | ||
| Q2 25 | $1.4B | $1.3B | ||
| Q1 25 | $2.8B | $1.1B | ||
| Q4 24 | $1.6B | $1.1B | ||
| Q3 24 | $1.5B | $1.0B | ||
| Q2 24 | $1.4B | $929.2M | ||
| Q1 24 | $2.9B | $751.7M |
| Q4 25 | $77.0M | $66.5M | ||
| Q3 25 | $64.0M | $124.8M | ||
| Q2 25 | $105.0M | $94.3M | ||
| Q1 25 | $453.0M | $1.3M | ||
| Q4 24 | $106.0M | $-151.9M | ||
| Q3 24 | $152.0M | $-121.3M | ||
| Q2 24 | $87.0M | $-120.4M | ||
| Q1 24 | $579.0M | $-251.2M |
| Q4 25 | 41.3% | 90.5% | ||
| Q3 25 | 41.3% | 86.1% | ||
| Q2 25 | 45.4% | 87.5% | ||
| Q1 25 | 46.7% | 85.2% | ||
| Q4 24 | 43.5% | 85.8% | ||
| Q3 24 | 41.0% | 83.0% | ||
| Q2 24 | 43.8% | 85.1% | ||
| Q1 24 | 45.9% | 83.4% |
| Q4 25 | 10.1% | 12.4% | ||
| Q3 25 | 10.1% | 11.5% | ||
| Q2 25 | 14.7% | 6.7% | ||
| Q1 25 | 24.3% | 1.0% | ||
| Q4 24 | 13.5% | -7.0% | ||
| Q3 24 | 12.0% | -12.0% | ||
| Q2 24 | 13.5% | -11.5% | ||
| Q1 24 | 23.9% | -34.8% |
| Q4 25 | 4.8% | 4.4% | ||
| Q3 25 | 4.1% | 8.8% | ||
| Q2 25 | 7.4% | 7.2% | ||
| Q1 25 | 16.3% | 0.1% | ||
| Q4 24 | 6.6% | -13.5% | ||
| Q3 24 | 10.0% | -12.1% | ||
| Q2 24 | 6.3% | -13.0% | ||
| Q1 24 | 19.9% | -33.4% |
| Q4 25 | $0.37 | $0.05 | ||
| Q3 25 | $0.30 | $0.08 | ||
| Q2 25 | $0.49 | $0.06 | ||
| Q1 25 | $2.06 | $0.00 | ||
| Q4 24 | $0.49 | $-0.10 | ||
| Q3 24 | $0.68 | $-0.09 | ||
| Q2 24 | $0.38 | $-0.09 | ||
| Q1 24 | $2.54 | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $236.0M | $4.5B |
| Total DebtLower is stronger | $3.9B | $836.4M |
| Stockholders' EquityBook value | $-1.6B | $4.4B |
| Total Assets | $5.0B | $8.2B |
| Debt / EquityLower = less leverage | — | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $236.0M | $4.5B | ||
| Q3 25 | $364.0M | $4.0B | ||
| Q2 25 | $636.0M | $2.8B | ||
| Q1 25 | $674.0M | $2.5B | ||
| Q4 24 | $191.0M | $2.6B | ||
| Q3 24 | $514.0M | $2.7B | ||
| Q2 24 | $855.0M | $2.6B | ||
| Q1 24 | $1.1B | $2.8B |
| Q4 25 | $3.9B | $836.4M | ||
| Q3 25 | $3.9B | — | ||
| Q2 25 | $3.9B | — | ||
| Q1 25 | $3.9B | — | ||
| Q4 24 | $4.2B | — | ||
| Q3 24 | $4.2B | — | ||
| Q2 24 | $4.3B | — | ||
| Q1 24 | $4.4B | — |
| Q4 25 | $-1.6B | $4.4B | ||
| Q3 25 | $-1.5B | $4.1B | ||
| Q2 25 | $-1.5B | $3.8B | ||
| Q1 25 | $-1.4B | $3.5B | ||
| Q4 24 | $-1.7B | $3.3B | ||
| Q3 24 | $-1.7B | $3.4B | ||
| Q2 24 | $-1.7B | $3.4B | ||
| Q1 24 | $-1.6B | $3.4B |
| Q4 25 | $5.0B | $8.2B | ||
| Q3 25 | $4.8B | $7.6B | ||
| Q2 25 | $4.9B | $6.3B | ||
| Q1 25 | $4.9B | $5.8B | ||
| Q4 24 | $5.0B | $5.9B | ||
| Q3 24 | $4.9B | $5.8B | ||
| Q2 24 | $5.2B | $5.7B | ||
| Q1 24 | $5.5B | $5.7B |
| Q4 25 | — | 0.19× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $80.0M | $417.3M |
| Free Cash FlowOCF − Capex | $-1.0M | $379.8M |
| FCF MarginFCF / Revenue | -0.1% | 25.4% |
| Capex IntensityCapex / Revenue | 5.1% | 2.5% |
| Cash ConversionOCF / Net Profit | 1.04× | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | $946.0M | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.0M | $417.3M | ||
| Q3 25 | $-43.0M | $402.6M | ||
| Q2 25 | $188.0M | $263.6M | ||
| Q1 25 | $955.0M | $44.1M | ||
| Q4 24 | $-99.0M | $75.2M | ||
| Q3 24 | $-46.0M | $188.4M | ||
| Q2 24 | $76.0M | $-95.6M | ||
| Q1 24 | $926.0M | $-308.6M |
| Q4 25 | $-1.0M | $379.8M | ||
| Q3 25 | $-99.0M | $354.5M | ||
| Q2 25 | $151.0M | $219.8M | ||
| Q1 25 | $895.0M | $-12.3M | ||
| Q4 24 | $-164.0M | $-17.3M | ||
| Q3 24 | $-101.0M | $54.7M | ||
| Q2 24 | $30.0M | $-205.5M | ||
| Q1 24 | $878.0M | $-465.1M |
| Q4 25 | -0.1% | 25.4% | ||
| Q3 25 | -6.4% | 25.1% | ||
| Q2 25 | 10.6% | 16.7% | ||
| Q1 25 | 32.1% | -1.1% | ||
| Q4 24 | -10.2% | -1.5% | ||
| Q3 24 | -6.6% | 5.5% | ||
| Q2 24 | 2.2% | -22.1% | ||
| Q1 24 | 30.2% | -61.9% |
| Q4 25 | 5.1% | 2.5% | ||
| Q3 25 | 3.6% | 3.4% | ||
| Q2 25 | 2.6% | 3.3% | ||
| Q1 25 | 2.2% | 5.0% | ||
| Q4 24 | 4.0% | 8.2% | ||
| Q3 24 | 3.6% | 13.3% | ||
| Q2 24 | 3.3% | 11.8% | ||
| Q1 24 | 1.6% | 20.8% |
| Q4 25 | 1.04× | 6.28× | ||
| Q3 25 | -0.67× | 3.22× | ||
| Q2 25 | 1.79× | 2.79× | ||
| Q1 25 | 2.11× | 34.71× | ||
| Q4 24 | -0.93× | — | ||
| Q3 24 | -0.30× | — | ||
| Q2 24 | 0.87× | — | ||
| Q1 24 | 1.60× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BBWI
| Bath Body Works Stores | $1.2B | 77% |
| Bath Body Works Direct | $299.0M | 19% |
| Bath Body Works International | $73.0M | 5% |
ONC
Segment breakdown not available.
